Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 185 articles:
HTML format
Text format



Single Articles


    August 2019
  1. TEN OEVER J, Jansen JL, van der Vaart TW, Schouten JA, et al
    Development of quality indicators for the management of Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2019 Aug 8. pii: 5545103. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2019
  2. COLLEY T, Sharma C, Alanio A, Kimura G, et al
    Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
    J Antimicrob Chemother. 2019 Jul 30. pii: 5540742. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. COUPRI D, Budin-Verneuil A, Hartke A, Benachour A, et al
    Genetic and pharmacological inactivation of d-alanylation of teichoic acids sensitizes pathogenic enterococci to beta-lactams.
    J Antimicrob Chemother. 2019 Jul 24. pii: 5538001. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. KLARE I, Bender JK, Fleige C, Kriebel N, et al
    Comparison of VITEK(R) 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs.
    J Antimicrob Chemother. 2019 Jul 23. pii: 5537362. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. RUDRAMURTHY SM, Colley T, Abdolrasouli A, Ashman J, et al
    In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.
    J Antimicrob Chemother. 2019 Jul 19. pii: 5536332. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. SHANG Y, Li D, Hao W, Schwarz S, et al
    A prophage and two ICESa2603-family integrative and conjugative elements (ICEs) carrying optrA in Streptococcus suis.
    J Antimicrob Chemother. 2019 Jul 17. pii: 5533309. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. HURLEY JC
    Studies of selective digestive decontamination as a natural experiment to evaluate topical antibiotic prophylaxis and cephalosporin use as population-level risk factors for enterococcal bacteraemia among ICU patients.
    J Antimicrob Chemother. 2019 Jul 17. pii: 5533112. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. DUSS FR, Garcia de la Maria C, Croxatto A, Giulieri S, et al
    Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
    J Antimicrob Chemother. 2019 Jul 11. pii: 5531247. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. MEHTA K, Ravimohan S, Pasipanodya JG, Srivastava S, et al
    Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.
    J Antimicrob Chemother. 2019 Jul 4. pii: 5528382. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. PI R, Liu Q, Jiang Q, Gao Q, et al
    Characterization of linezolid-resistance-associated mutations in Mycobacterium tuberculosis through WGS.
    J Antimicrob Chemother. 2019;74:1795-1798.
    PubMed     Text format     Abstract available


  11. WURSTER S, Bandi A, Beyda ND, Albert ND, et al
    Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
    J Antimicrob Chemother. 2019;74:1904-1910.
    PubMed     Text format     Abstract available


  12. GONZALEZ-LARA MF, Roman-Montes CM, Diaz-Lomeli P, Rangel-Cordero A, et al
    Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    J Antimicrob Chemother. 2019;74:2047-2050.
    PubMed     Text format     Abstract available


    June 2019
  13. ELGHAIEB H, Freitas AR, Abbassi MS, Novais C, et al
    Dispersal of linezolid-resistant enterococci carrying poxtA or optrA in retail meat and food-producing animals from Tunisia.
    J Antimicrob Chemother. 2019 Jun 26. pii: 5523711. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. CHANCHAITHONG P, Perreten V, Schwendener S
    Macrococcus canis contains recombinogenic methicillin resistance elements and the mecB plasmid found in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Jun 26. pii: 5523695. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. HUANG J, Wang M, Gao Y, Chen L, et al
    Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin.
    J Antimicrob Chemother. 2019 Jun 24. pii: 5522517. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. RESENDIZ-SHARPE A, Mercier T, Lestrade PPA, van der Beek MT, et al
    Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
    J Antimicrob Chemother. 2019 Jun 24. pii: 5522515. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. LEON-SAMPEDRO R, Fernandez-de-Bobadilla MD, San Millan A, Baquero F, et al
    Transfer dynamics of Tn6648, a composite integrative conjugative element generated by tandem accretion of Tn5801 and Tn6647 in Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Jun 21. pii: 5521775. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. LENHARD JR, Smith NM, Quach CD, Nguyen TQ, et al
    Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposure.
    J Antimicrob Chemother. 2019 Jun 20. pii: 5521061. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. SHEN P, Zhou K, Wang Y, Song J, et al
    High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
    J Antimicrob Chemother. 2019 Jun 15. pii: 5519372. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2019
  20. PINTO SN, Dias SA, Cruz AF, Mil-Homens D, et al
    The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms.
    J Antimicrob Chemother. 2019 May 24. pii: 5498604. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. JAJOU R, van der Laan T, de Zwaan R, Kamst M, et al
    WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing.
    J Antimicrob Chemother. 2019 May 22. pii: 5497435. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. CHANG SC, Lin LC, Ge MC, Liu TP, et al
    Characterization of a novel, type II staphylococcal cassette chromosome mec element from an endemic oxacillin-resistant Staphylococcus lugdunensis clone in a hospital setting.
    J Antimicrob Chemother. 2019 May 18. pii: 5491489. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. MORIO F, Lombardi L, Binder U, Loge C, et al
    Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
    J Antimicrob Chemother. 2019 May 18. pii: 5491491. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. MELETIADIS J, Siopi M, Kanioura L, Jorgensen KM, et al
    Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.
    J Antimicrob Chemother. 2019 May 18. pii: 5491493. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. LEI CW, Kang ZZ, Wu SK, Chen YP, et al
    Detection of the phenicol-oxazolidinone-tetracycline resistance gene poxtA in Enterococcus faecium and Enterococcus faecalis of food-producing animal origin in China.
    J Antimicrob Chemother. 2019 May 18. pii: 5491555. doi: 10.1093.
    PubMed     Text format    


  26. YUSTE JR, Serrano-Alonso M, Carmona-Torre F, Del Pozo JL, et al
    Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis.
    J Antimicrob Chemother. 2019 May 18. pii: 5491490. doi: 10.1093.
    PubMed     Text format    


  27. DUDIUK C, Berrio I, Leonardelli F, Morales-Lopez S, et al
    Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.
    J Antimicrob Chemother. 2019 May 12. pii: 5488498. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. REED JM, Gardner SG, Mishra NN, Bayer AS, et al
    Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 May 10. pii: 5487738. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. LORENZO MP, Kidd JM, Jenkins SG, Nicolau DP, et al
    In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium.
    J Antimicrob Chemother. 2019 May 3. pii: 5485296. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. BARMAN TK, Kumar M, Chaira T, Gangadharan R, et al
    Potential of the fluoroketolide RBx 14255 against Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae in an experimental murine meningitis model.
    J Antimicrob Chemother. 2019 May 2. pii: 5485015. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2019
  31. LAVERGNE RA, Morio F, Danner-Boucher I, Horeau-Langlard D, et al
    One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance.
    J Antimicrob Chemother. 2019 Apr 30. pii: 5481886. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. PAPAGIANNITSIS CC, Tsilipounidaki K, Malli E, Petinaki E, et al
    Detection in Greece of a clinical Enterococcus faecium isolate carrying the novel oxazolidinone resistance gene poxtA.
    J Antimicrob Chemother. 2019 Apr 22. pii: 5476265. doi: 10.1093.
    PubMed     Text format    


  33. WICHA WW, Strickmann DB, Paukner S
    Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model with Staphylococcus aureus and Streptococcus pneumoniae.
    J Antimicrob Chemother. 2019;74.
    PubMed     Text format     Abstract available


    March 2019
  34. PINHOLT M, Bayliss SC, Gumpert H, Worning P, et al
    WGS of 1058 Enterococcus faecium from Copenhagen, Denmark, reveals rapid clonal expansion of vancomycin-resistant clone ST80 combined with widespread dissemination of a vanA-containing plasmid and acquisition of a heterogeneous accessory genome.
    J Antimicrob Chemother. 2019 Mar 30. pii: 5423852. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. SASSI M, Guerin F, Zouari A, Beyrouthy R, et al
    Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16.
    J Antimicrob Chemother. 2019 Mar 20. pii: 5416192. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. RIVERO-MENENDEZ O, Cuenca-Estrella M, Alastruey-Izquierdo A
    In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies.
    J Antimicrob Chemother. 2019 Mar 19. pii: 5396709. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. HAO W, Shan X, Li D, Schwarz S, et al
    Analysis of a poxtA- and optrA-co-carrying conjugative multiresistance plasmid from Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Mar 19. pii: 5396705. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. VASUDEVAN S, Durai RD, Chellappan DR, Narayanan VHB, et al
    A polymer-based anti-quorum catheter coating to challenge MDR Staphylococcus aureus: in vivo and in vitro approaches.
    J Antimicrob Chemother. 2019 Mar 12. pii: 5377359. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. HASMAN H, Clausen PTLC, Kaya H, Hansen F, et al
    LRE-Finder, a Web tool for detection of the 23S rRNA mutations and the optrA, cfr, cfr(B) and poxtA genes encoding linezolid resistance in enterococci from whole-genome sequences.
    J Antimicrob Chemother. 2019 Mar 12. pii: 5377356. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. MAXWELL-SCOTT H, Thangarajah R, Arnold A, Wade P, et al
    Successful treatment of Pseudomonas aeruginosa infective endocarditis via haemodialysis outpatient parenteral antimicrobial therapy: case report.
    J Antimicrob Chemother. 2019 Mar 4. pii: 5369201. doi: 10.1093.
    PubMed     Text format    


    February 2019
  41. PERISELNERIS J, Nwankwo L, Schelenz S, Shah A, et al
    Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    J Antimicrob Chemother. 2019 Feb 25. pii: 5364630. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. FARHAT MR, Sixsmith J, Calderon R, Hicks ND, et al
    Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
    J Antimicrob Chemother. 2019 Feb 21. pii: 5359497. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. HU Y, Pertinez H, Liu Y, Davies G, et al
    Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.
    J Antimicrob Chemother. 2019 Feb 20. pii: 5353164. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. KANG J, Dietz MJ, Hughes K, Xing M, et al
    Silver nanoparticles present high intracellular and extracellular killing against Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Feb 18. pii: 5333167. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. BA X, Kalmar L, Hadjirin NF, Kerschner H, et al
    Truncation of GdpP mediates beta-lactam resistance in clinical isolates of Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Feb 12. pii: 5316432. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. SINGH A, Singh PK, de Groot T, Kumar A, et al
    Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315659. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. LAMOTH F, Mercier T, Andre P, Pagani JL, et al
    Isavuconazole brain penetration in cerebral aspergillosis.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315664. doi: 10.1093.
    PubMed     Text format    


  48. NIKOLAYEVSKYY V, Maurer FP, Holicka Y, Taylor L, et al
    Novel external quality assurance scheme for drug susceptibility testing of non-tuberculous mycobacteria: a multicentre pilot study.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315667. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. WU T, Meyer K, Harrington AT, Danziger LH, et al
    In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    J Antimicrob Chemother. 2019 Feb 8. pii: 5310330. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. DAS S, Garg T, Chopra S, Dasgupta A, et al
    Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2019 Feb 7. pii: 5309031. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. SADER HS, Mendes RE, Pfaller MA, Flamm RK, et al
    Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres.
    J Antimicrob Chemother. 2019 Feb 7. pii: 5309029. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. PAUL S, Singh S, Chakrabarti A, Rudramurthy SM, et al
    Stable isotope labelling: an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance in Candida tropicalis.
    J Antimicrob Chemother. 2019 Feb 6. pii: 5307967. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2019
  53. PEREZ-RODRIGUEZ MT, Sousa A, Lopez-Cortes LE, Martinez-Lamas L, et al
    Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2019 Jan 27. pii: 5303230. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. DEL PRINCIPE MI, Dragonetti G, Verga L, Candoni A, et al
    'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.
    J Antimicrob Chemother. 2019 Jan 14. pii: 5289513. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. KITAMURA M, Kimura K, Ido A, Seki T, et al
    Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in Japan.
    J Antimicrob Chemother. 2019 Jan 11. pii: 5288581. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. MORRONI G, Brenciani A, Litta-Mulondo A, Vignaroli C, et al
    Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288148. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. RUTH MM, Sangen JJN, Remmers K, Pennings LJ, et al
    A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288158. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. DE JONG A, Simjee S, Rose M, Moyaert H, et al
    Antimicrobial resistance monitoring in commensal enterococci from healthy cattle, pigs and chickens across Europe during 2004-14 (EASSA Study).
    J Antimicrob Chemother. 2019 Jan 8. pii: 5280942. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2018
  59. KOSMIDIS C, Rodriguez-Goncer I, Rautemaa-Richardson R, Richardson MD, et al
    Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
    J Antimicrob Chemother. 2018 Dec 26. pii: 5262264. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. MACFADYEN AC, Harrison EM, Drigo I, Parkhill J, et al
    A mecC allotype, mecC3, in the CoNS Staphylococcus caeli, encoded within a variant SCCmecC.
    J Antimicrob Chemother. 2018 Dec 22. pii: 5258045. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. RYBAK JM, Fortwendel JR, Rogers PD
    Emerging threat of triazole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 Dec 17. pii: 5250853. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. KIDD JM, Abdelraouf K, Nicolau DP
    Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
    J Antimicrob Chemother. 2018 Dec 14. pii: 5248203. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. BRENCIANI A, Fioriti S, Morroni G, Cucco L, et al
    Detection in Italy of a porcine Enterococcus faecium isolate carrying the novel phenicol-oxazolidinone-tetracycline resistance gene poxtA.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230877. doi: 10.1093.
    PubMed     Text format    


  64. ABAD L, Tafani V, Tasse J, Josse J, et al
    Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230874. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. ACCOCEBERRY I, Couzigou C, Fitton-Ouhabi V, Biteau N, et al
    Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230873. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. AKKERMAN OW, Alffenaar JWC
    Comment on: The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    J Antimicrob Chemother. 2018 Dec 1. pii: 5224542. doi: 10.1093.
    PubMed     Text format    


    November 2018
  67. JIANG N, Li J, Fessler AT, Wang Y, et al
    Novel pseudo-staphylococcal cassette chromosome mec element (phiSCCmecT55) in MRSA ST9.
    J Antimicrob Chemother. 2018 Nov 15. pii: 5184555. doi: 10.1093.
    PubMed     Text format    


  68. TREVINO-RANGEL RJ, Villanueva-Lozano H, Mendez-Galomo KS, Solis-Villegas EM, et al
    In vivo evaluation of the antifungal activity of sertraline against Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 Nov 6. pii: 5162960. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. LACKNER M, Birch M, Naschberger V, Grassle D, et al
    Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
    J Antimicrob Chemother. 2018;73:3068-3073.
    PubMed     Text format     Abstract available


    October 2018
  70. DAS S, Li J, Iaconis J, Zhou D, et al
    Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.
    J Antimicrob Chemother. 2018 Oct 31. pii: 5150590. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. NADERI J, Giles C, Saboohi S, Griesser HJ, et al
    Surface coatings with covalently attached anidulafungin and micafungin prevent Candida albicans biofilm formation.
    J Antimicrob Chemother. 2018 Oct 29. pii: 5146520. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. TROEMAN DPR, Van Hout D, Kluytmans JAJW
    Antimicrobial approaches in the prevention of Staphylococcus aureus infections: a review.
    J Antimicrob Chemother. 2018 Oct 29. pii: 5146516. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. LOPEZ B, Siqueira de Oliveira R, Pinhata JMW, Chimara E, et al
    Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
    J Antimicrob Chemother. 2018 Oct 25. pii: 5144701. doi: 10.1093.
    PubMed     Text format     Abstract available


  74. CAMPBELL AJ, Dotel R, Blyth CC, Davis JS, et al
    Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal.
    J Antimicrob Chemother. 2018 Oct 10. pii: 5126432. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. DOAN TN, Fox GJ, Meehan MT, Scott N, et al
    Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
    J Antimicrob Chemother. 2018 Oct 5. pii: 5116208. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. TYSON GH, Sabo JL, Hoffmann M, Hsu CH, et al
    Novel linezolid resistance plasmids in Enterococcus from food animals in the USA.
    J Antimicrob Chemother. 2018 Oct 1. pii: 5106682. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  77. XHEMALI X, Smith JR, Kebriaei R, Rice SA, et al
    Evaluation of dalbavancin alone and in combination with beta-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Sep 27. pii: 5107805. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. AUTMIZGUINE J, Smith PB, Prather K, Bendel C, et al
    Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.
    J Antimicrob Chemother. 2018 Sep 20. pii: 5104445. doi: 10.1093.
    PubMed     Text format     Abstract available


  79. ZHOU X, Chlebowicz MA, Bathoorn E, Rosema S, et al
    Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements.
    J Antimicrob Chemother. 2018 Sep 14. pii: 5096847. doi: 10.1093.
    PubMed     Text format     Abstract available


  80. CHANNABASAPPA S, Chikkamadaiah R, Durgaiah M, Kumar S, et al
    Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice.
    J Antimicrob Chemother. 2018 Sep 11. pii: 5095203. doi: 10.1093.
    PubMed     Text format     Abstract available


  81. LEE RS, Goncalves da Silva A, Baines SL, Strachan J, et al
    The changing landscape of vancomycin-resistant Enterococcus faecium in Australia: a population-level genomic study.
    J Antimicrob Chemother. 2018 Sep 4. pii: 5090546. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  82. PASQUAROLI S, Citterio B, Mangiaterra G, Biavasco F, et al
    Influence of sublethal concentrations of vancomycin and quinupristin/dalfopristin on the persistence of viable but non-culturable Staphylococcus aureus growing in biofilms.
    J Antimicrob Chemother. 2018 Aug 29. pii: 5086495. doi: 10.1093.
    PubMed     Text format    


  83. CAMARA J, Cubero M, Martin-Galiano AJ, Garcia E, et al
    Evolution of the beta-lactam-resistant Streptococcus pneumoniae PMEN3 clone over a 30 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5079858. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. MACFADYEN AC, Harrison EM, Ellington MJ, Parkhill J, et al
    A highly conserved mecC-encoding SCCmec type XI in a bovine isolate of methicillin-resistant Staphylococcus xylosus.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5084893. doi: 10.1093.
    PubMed     Text format    


  85. RIGAILL J, Morgene MF, Gavid M, Lelonge Y, et al
    Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization.
    J Antimicrob Chemother. 2018 Aug 16. pii: 5075188. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. DEPLANO A, Dodemont M, Denis O, Westh H, et al
    European external quality assessments for identification, molecular typing and characterization of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Aug 7. pii: 5067736. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. HANSEN TA, Pedersen MS, Nielsen LG, Ma CMG, et al
    Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX.
    J Antimicrob Chemother. 2018 Aug 2. pii: 5064278. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. BERKOW EL, Lockhart SR
    Activity of novel antifungal compound APX001A against a large collection of Candida auris.
    J Antimicrob Chemother. 2018 Aug 1. pii: 5063540. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  89. WIEDERHOLD NP, Locke JB, Daruwala P, Bartizal K, et al
    Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
    J Antimicrob Chemother. 2018 Jul 18. pii: 5055842. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. ROGIERS O, Holtappels M, Siala W, Lamkanfi M, et al
    Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.
    J Antimicrob Chemother. 2018 Jul 13. pii: 5053967. doi: 10.1093.
    PubMed     Text format     Abstract available


  91. WHITFIELD MG, Warren RM, Mathys V, Scott L, et al
    The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    J Antimicrob Chemother. 2018 Jul 5. pii: 5049577. doi: 10.1093.
    PubMed     Text format     Abstract available


  92. GOLDEN AR, Adam HJ, Karlowsky JA, Baxter M, et al
    Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  93. ADAM HJ, Golden AR, Karlowsky JA, Baxter MR, et al
    Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  94. ZHANEL GG, Adam HJ
    Introduction to the SAVE study (2011-15): Streptococcus pneumoniae serotyping and antimicrobial susceptibility: Assessment for Vaccine Efficacy in Canada after the introduction of PCV-13.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  95. KARLOWSKY JA, Adam HJ, Golden AR, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


    June 2018
  96. GARVEY EP, Sharp AD, Warn PA, Yates CM, et al
    The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis.
    J Antimicrob Chemother. 2018 Jun 26. pii: 5045560. doi: 10.1093.
    PubMed     Text format     Abstract available


  97. TAVERNIER S, Sass A, De Bruyne M, Baeke F, et al
    Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036452. doi: 10.1093.
    PubMed     Text format     Abstract available


  98. BOUDJEMAA R, Steenkeste K, Jacqueline C, Briandet R, et al
    Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure: observations in an in vivo mouse model of prosthetic vascular material infections.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036450. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. DESHPANDE LM, Castanheira M, Flamm RK, Mendes RE, et al
    Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.
    J Antimicrob Chemother. 2018 Jun 6. pii: 5033815. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  100. TALBOT JJ, Subedi S, Halliday CL, Hibbs DE, et al
    Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    J Antimicrob Chemother. 2018 May 29. pii: 5018389. doi: 10.1093.
    PubMed     Text format     Abstract available


  101. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 May 25. pii: 5003466. doi: 10.1093.
    PubMed     Text format    


  102. BREAK TJ, Desai JV, Healey KR, Natarajan M, et al
    VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.
    J Antimicrob Chemother. 2018 May 16. pii: 4996888. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  103. SEUFERT R, Sedlacek L, Kahl B, Hogardt M, et al
    Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.
    J Antimicrob Chemother. 2018 Apr 19. pii: 4978322. doi: 10.1093.
    PubMed     Text format     Abstract available


  104. HAGER CL, Larkin EL, Long LA, Ghannoum MA, et al
    Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model.
    J Antimicrob Chemother. 2018 Apr 19. pii: 4979534. doi: 10.1093.
    PubMed     Text format     Abstract available


  105. RIZZATO C, Poma N, Zoppo M, Posteraro B, et al
    CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates.
    J Antimicrob Chemother. 2018 Apr 9. pii: 4964989. doi: 10.1093.
    PubMed     Text format     Abstract available


  106. ARGUDIN MA, Dodemont M, Taguemount M, Roisin S, et al
    In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    J Antimicrob Chemother. 2018 Apr 5. pii: 4962127. doi: 10.1093.
    PubMed     Text format    


  107. HASHEMI MM, Rovig J, Holden BS, Taylor MF, et al
    Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960903. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  108. CANEZIN PH, Caleffi-Ferracioli KR, Scodro RBL, Siqueira VLD, et al
    Intramacrophage Mycobacterium tuberculosis efflux pump gene regulation after rifampicin and verapamil exposure.
    J Antimicrob Chemother. 2018 Mar 22. pii: 4951545. doi: 10.1093.
    PubMed     Text format     Abstract available


  109. VAN HAL SJ, Beukers AG, Timms VJ, Ellem JA, et al
    Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
    J Antimicrob Chemother. 2018 Mar 16. pii: 4939528. doi: 10.1093.
    PubMed     Text format     Abstract available


  110. DALL GF, Tsang SJ, Gwynne PJ, MacKenzie SP, et al
    Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms.
    J Antimicrob Chemother. 2018 Mar 14. pii: 4937886. doi: 10.1093.
    PubMed     Text format     Abstract available


  111. CARTER GP, Harjani JR, Li L, Pitcher NP, et al
    1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    J Antimicrob Chemother. 2018 Mar 6. pii: 4922693. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  112. THIEME L, Klinger-Strobel M, Hartung A, Stein C, et al
    In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    J Antimicrob Chemother. 2018 Feb 28. pii: 4913717. doi: 10.1093.
    PubMed     Text format     Abstract available


  113. MCCARTY TP, Lockhart SR, Moser SA, Whiddon J, et al
    Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.
    J Antimicrob Chemother. 2018 Feb 28. pii: 4913721. doi: 10.1093.
    PubMed     Text format     Abstract available


  114. RODRIGUEZ-CASTRO E, Trastoy R, Rodriguez-Osorio X, Dominguez-Santalla MJ, et al
    Meningitis due to autochthonous acute infection with hepatitis E virus in a chef: a case report.
    J Antimicrob Chemother. 2018 Feb 21. pii: 4898172. doi: 10.1093.
    PubMed     Text format    


  115. LEBRETON F, Valentino MD, Schaufler K, Earl AM, et al
    Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    J Antimicrob Chemother. 2018 Feb 14. pii: 4859672. doi: 10.1093.
    PubMed     Text format     Abstract available


  116. WESSELS C, Strommenger B, Klare I, Bender J, et al
    Emergence and control of linezolid-resistant Staphylococcus epidermidis in an ICU of a German hospital.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847818. doi: 10.1093.
    PubMed     Text format     Abstract available


  117. KAMBAREV S, Pecorari F, Corvec S
    Novel Tn916-like elements confer aminoglycoside/macrolide co-resistance in clinical isolates of Streptococcus gallolyticus ssp. gallolyticus.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847819. doi: 10.1093.
    PubMed     Text format     Abstract available


  118. SUN C, Zhang P, Ji X, Fan R, et al
    Presence and molecular characteristics of oxazolidinone resistance in staphylococci from household animals in rural China.
    J Antimicrob Chemother. 2018 Feb 7. pii: 4841776. doi: 10.1093.
    PubMed     Text format     Abstract available


  119. HUH HJ, Song DJ, Shim HJ, Kwon WK, et al
    Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture: a comparative study of performance with the VITEK-2 system.
    J Antimicrob Chemother. 2018 Feb 3. pii: 4837262. doi: 10.1093.
    PubMed     Text format     Abstract available


  120. NEVES FPG, Cardoso NT, Souza ARV, Snyder RE, et al
    Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage.
    J Antimicrob Chemother. 2018 Feb 1. pii: 4833983. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  121. LESTRADE PP, van der Velden WJFM, Bouwman F, Stoop FJ, et al
    Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study.
    J Antimicrob Chemother. 2018 Jan 31. pii: 4831957. doi: 10.1093.
    PubMed     Text format     Abstract available


  122. DOOKIE N, Rambaran S, Padayatchi N, Mahomed S, et al
    Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817621. doi: 10.1093.
    PubMed     Text format     Abstract available


  123. LAYER F, Vourli S, Karavasilis V, Strommenger B, et al
    Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817623. doi: 10.1093.
    PubMed     Text format     Abstract available


  124. SASSI M, Guerin F, Lesec L, Isnard C, et al
    Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    J Antimicrob Chemother. 2018 Jan 16. pii: 4812002. doi: 10.1093.
    PubMed     Text format     Abstract available


  125. REISSIER S, Saleh-Mghir A, Guerin F, Massias L, et al
    In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4796903. doi: 10.1093.
    PubMed     Text format     Abstract available


  126. CHOWDHARY A, Prakash A, Sharma C, Kordalewska M, et al
    A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4794718. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  127. VAN DEN BUNT G, Top J, Hordijk J, de Greeff SC, et al
    Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774625. doi: 10.1093.
    PubMed     Text format     Abstract available


  128. EDSLEV SM, Clausen ML, Agner T, Stegger M, et al
    Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745837. doi: 10.1093.
    PubMed     Text format     Abstract available


  129. LIU Y, Pertinez H, Ortega-Muro F, Alameda-Martin L, et al
    Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
    J Antimicrob Chemother. 2017 Dec 12. pii: 4735127. doi: 10.1093.
    PubMed     Text format     Abstract available


  130. CHEN C, Hooper DC
    Effect of Staphylococcus aureus Tet38 native efflux pump on in vivo response to tetracycline in a murine subcutaneous abscess model.
    J Antimicrob Chemother. 2017 Dec 5. pii: 4693732. doi: 10.1093.
    PubMed     Text format     Abstract available


  131. ZHANG P, Wright JA, Tymon A, Nair SP, et al
    Bicarbonate induces high-level resistance to the human antimicrobial peptide LL-37 in Staphylococcus aureus small colony variants.
    J Antimicrob Chemother. 2017 Dec 4. pii: 4688916. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  132. PITT R, Alexander S, Ison C, Horner P, et al
    Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    J Antimicrob Chemother. 2017 Nov 30. pii: 4682922. doi: 10.1093.
    PubMed     Text format     Abstract available


  133. KONTOYIANNIS DP, Selleslag D, Mullane K, Cornely OA, et al
    Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
    J Antimicrob Chemother. 2017 Nov 29. pii: 4675068. doi: 10.1093.
    PubMed     Text format     Abstract available


  134. WIEDERHOLD NP, Patterson HP, Tran BH, Yates CM, et al
    Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus.
    J Antimicrob Chemother. 2017 Nov 27. pii: 4669681. doi: 10.1093.
    PubMed     Text format     Abstract available


  135. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
    J Antimicrob Chemother. 2017 Nov 23. pii: 4654829. doi: 10.1093.
    PubMed     Text format     Abstract available


  136. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2017 Nov 21. pii: 4644442. doi: 10.1093.
    PubMed     Text format     Abstract available


  137. FREITAS AR, Tedim AP, Novais C, Coque TM, et al
    Distribution of putative virulence markers in Enterococcus faecium: towards a safety profile review.
    J Antimicrob Chemother. 2017 Nov 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  138. COSTA SS, Viveiros M, Pomba C, Couto I, et al
    Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen.
    J Antimicrob Chemother. 2017 Nov 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  139. GODET C, Alastruey-Izquierdo A, Flick H, Hennequin C, et al
    A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention.
    J Antimicrob Chemother. 2017 Nov 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  140. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Nov 3. doi: 10.1093.
    PubMed     Text format    


    October 2017
  141. DORTET L, Glaser P, Kassis-Chikhani N, Girlich D, et al
    Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  142. VYAZOVAYA A, Levina K, Zhuravlev V, Viiklepp P, et al
    Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  143. FOSCHI C, Salvo M, Cevenini R, Marangoni A, et al
    Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
    J Antimicrob Chemother. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  144. CHEN CJ, Lauderdale TY, Lu CT, Chuang YY, et al
    Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  145. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  146. SEAS C, Garcia C, Salles MJ, Labarca J, et al
    Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.
    J Antimicrob Chemother. 2017 Oct 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  147. BREAK TJ, Desai JV, Natarajan M, Ferre EMN, et al
    VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  148. HOLYK A, Belden V, Lee JJ, Musick W, et al
    Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format    


  149. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  150. YEW WW, Liang D, Chan DP, Shi W, et al
    Molecular mechanisms of clofazimine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017;72:2943-2944.
    PubMed     Text format    


  151. SINGH R, Almutairi M, Alm RA, Lahiri SD, et al
    Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.
    J Antimicrob Chemother. 2017;72:2796-2803.
    PubMed     Text format     Abstract available


  152. SCORNEC H, Bellanger X, Guilloteau H, Groshenry G, et al
    Inducibility of Tn916 conjugative transfer in Enterococcus faecalis by subinhibitory concentrations of ribosome-targeting antibiotics.
    J Antimicrob Chemother. 2017;72:2722-2728.
    PubMed     Text format     Abstract available


  153. DOUMITH M, Mushtaq S, Martin V, Chaudhry A, et al
    Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance.
    J Antimicrob Chemother. 2017;72:2704-2707.
    PubMed     Text format     Abstract available


  154. ZHANG Y, Kashikar A, Bush K
    In vitro activity of plazomicin against beta-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
    J Antimicrob Chemother. 2017;72:2792-2795.
    PubMed     Text format     Abstract available


  155. BRENNAN-KROHN T, Truelson KA, Smith KP, Kirby JE, et al
    Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
    J Antimicrob Chemother. 2017;72:2775-2781.
    PubMed     Text format     Abstract available


    September 2017
  156. FREITAS AR, Elghaieb H, Leon-Sampedro R, Abbassi MS, et al
    Detection of optrA in the African continent (Tunisia) within a mosaic Enterococcus faecalis plasmid from urban wastewaters.
    J Antimicrob Chemother. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  157. CHEN J, Zhang S, Cui P, Shi W, et al
    Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Sep 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  158. WU CJ, Lai JF, Huang IW, Hsieh LY, et al
    Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    J Antimicrob Chemother. 2017 Sep 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  159. PASIPANODYA JG, Ogbonna D, Deshpande D, Srivastava S, et al
    Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  160. DESHPANDE D, Srivastava S, Gumbo T
    A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  161. DESHPANDE D, Srivastava S, Pasipanodya JG, Lee PS, et al
    A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  162. DESHPANDE D, Srivastava S, Pasipanodya JG, Lee PS, et al
    Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  163. DESHPANDE D, Srivastava S, Pasipanodya JG, Gumbo T, et al
    Linezolid as treatment for pulmonary Mycobacterium avium disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  164. SRIVASTAVA S, Deshpande D, Gumbo T
    Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


    August 2017
  165. LAZARIS A, Coleman DC, Kearns AM, Pichon B, et al
    Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
    J Antimicrob Chemother. 2017 Aug 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  166. CHANG SC, Lee MH, Yeh CF, Liu TP, et al
    Characterization of two novel variants of staphylococcal cassette chromosome mec elements in oxacillin-resistant Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  167. GONZALEZ MORENO M, Trampuz A, Di Luca M
    Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis.
    J Antimicrob Chemother. 2017 Aug 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  168. SINGH AK, Thakare R, Karaulia P, Das S, et al
    Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections.
    J Antimicrob Chemother. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  169. SCHAUWVLIEGHE AFAD, Vonk AG, Buddingh EP, Hoek RAS, et al
    Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  170. WEBER RE, Layer F, Klare I, Werner G, et al
    Comparative evaluation of VITEK(R) 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  171. COJUTTI PG, Candoni A, Ramos-Martin V, Lazzarotto D, et al
    Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.
    J Antimicrob Chemother. 2017;72:2342-2350.
    PubMed     Text format     Abstract available


  172. CORNELY OA, Leguay T, Maertens J, Vehreschild MJGT, et al
    Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
    J Antimicrob Chemother. 2017;72:2359-2367.
    PubMed     Text format     Abstract available


  173. TAUBERT M, Zander J, Frechen S, Scharf C, et al
    Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens.
    J Antimicrob Chemother. 2017;72:2304-2310.
    PubMed     Text format     Abstract available


  174. BEVAN ER, Jones AM, Hawkey PM
    Global epidemiology of CTX-M beta-lactamases: temporal and geographical shifts in genotype.
    J Antimicrob Chemother. 2017;72:2145-2155.
    PubMed     Text format     Abstract available


  175. AYDIN S, Personne Y, Newire E, Laverick R, et al
    Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli.
    J Antimicrob Chemother. 2017;72:2213-2218.
    PubMed     Text format     Abstract available


  176. MATSUMURA Y, Peirano G, Devinney R, Bradford PA, et al
    Genomic epidemiology of global VIM-producing Enterobacteriaceae.
    J Antimicrob Chemother. 2017;72:2249-2258.
    PubMed     Text format     Abstract available


  177. SVENSSON RJ, Gillespie SH, Simonsson USH
    Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
    J Antimicrob Chemother. 2017;72:2311-2319.
    PubMed     Text format     Abstract available


  178. LIVERMORE DM, Mushtaq S, Meunier D, Hopkins KL, et al
    Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles.
    J Antimicrob Chemother. 2017;72:2278-2289.
    PubMed     Text format     Abstract available


  179. BOTELHO J, Grosso F, Quinteira S, Mabrouk A, et al
    The complete nucleotide sequence of an IncP-2 megaplasmid unveils a mosaic architecture comprising a putative novel blaVIM-2-harbouring transposon in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2017;72:2225-2229.
    PubMed     Text format     Abstract available


  180. LAGACE-WIENS PRS, Adam HJ, Laing NM, Baxter MR, et al
    Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.
    J Antimicrob Chemother. 2017;72:2273-2277.
    PubMed     Text format     Abstract available


  181. CHATTERJEE S, Mondal A, Mitra S, Basu S, et al
    Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles.
    J Antimicrob Chemother. 2017;72:2201-2207.
    PubMed     Text format     Abstract available


  182. VARGAS-PALACIOS A, Meads DM, Twiddy M, Czoski Murray C, et al
    Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.
    J Antimicrob Chemother. 2017;72:2392-2400.
    PubMed     Text format     Abstract available


  183. SMITH NM, Bulman ZP, Sieron AO, Bulitta JB, et al
    Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli.
    J Antimicrob Chemother. 2017;72:2297-2303.
    PubMed     Text format     Abstract available


  184. DOUMITH M, Findlay J, Hirani H, Hopkins KL, et al
    Major role of pKpQIL-like plasmids in the early dissemination of KPC-type carbapenemases in the UK.
    J Antimicrob Chemother. 2017;72:2241-2248.
    PubMed     Text format     Abstract available


    July 2017
  185. FIRSOV AA, Alieva KN, Strukova EN, Golikova MV, et al
    Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
    J Antimicrob Chemother. 2017 Jul 31. doi: 10.1093.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: